Table 3.
Interpretation and discussion of MMR/MSI test results.
| All Physicians (n = 151); n (%) |
Physician Specialty | |||
|---|---|---|---|---|
| Oncologist (n = 91); n (%) |
Pathologist (n = 45); n (%) |
Surgeon/Surgical Oncologist (n = 15); n (%) |
||
| Do you interpret the lab clinical test results of the MMR/MSI testing? * | ||||
| Yes, individually | 102 (67.5%) | 63 (69.2%) | 35 (77.8%) | 4 (26.7%) |
| Yes, as part of a multidisciplinary team | 47 (31.1%) | 30 (33.0%) | 7 (15.6%) | 10 (66.7%) |
| No, another physician interprets | 19 (12.6%) | 10 (11.0%) | 6 (13.3%) | 3 (20.0%) |
| Do you make treatment recommendations based on the lab results of the MMR/MSI testing? * | ||||
| Yes, individually | 92 (60.9%) | 79 (86.8%) | 9 (20.0%) | 4 (26.7%) |
| Yes, as part of a multidisciplinary team | 66 (43.7%) | 34 (37.4%) | 17 (37.8%) | 15 (100%) |
| No, another physician makes recommendations | 22 (14.6%) | - | 22 (48.9%) | - |
| Do you discuss with patients what MMR/MSI testing is and how it can impact patient care? | ||||
| Yes, discuss with patient before the test only | 6 (4.0%) | 5 (5.5%) | 1 (2.2%) | - |
| Yes, discuss with patient after the test only | 42 (27.8%) | 34 (37.4%) | 3 (6.7%) | 5 (33.3%) |
| Yes, discuss with patient before and after the test | 63 (41.7%) | 52 (57.1%) | 2 (4.4%) | 9 (60.0%) |
| No, a physician from another specialty communicates | 39 (25.8%) | - | 38 (84.4%) | 1 (6.7%) |
| Other ** | 1 (0.7%) | - | 1 (2.2%) | - |
* Multiple selections were allowed. Thus, toal percentage will not add up to 100%. ** Answer included: oncologist treating the patient discuss.